54 results about "Graft procedure" patented technology

A method is disclosed for preparing a soft tissue site, and augmenting the soft tissue site, such as the breast(s), scar, depression, or other defect, of a subject through use of devices that exert a distractive force on the breast(s) and grafting of autologous fat tissue such as domes with sealing rims for surrounding each of the soft tissue site and a regulated pump. The method for preparing the soft tissue site, and enhancing fat graft results, entails application of the distracting force to the targeted soft tissue site at least intermittently for some period of time and preferably several weeks prior to the graft procedure. A related aspect of the invention includes following the preparation steps by transfer of fat from other areas of the subject to the subject's soft tissue site, and then reapplication of the distractive force to the soft tissue site that received the autologous fat graft. Alternatively, fat from genetically related sources may be used, and the fat may be further processed prior to injection. Substantial soft tissue augmentation, high rates of graft survival and negligible graft necrosis (data demonstrating 80% survival and only 20% necrosis is presented) or calcification result from the practice of these methods.

A method for performing a coronary artery bypass graft procedure on a patient to connect a bypass vessel to a target vessel includes the steps of creating an opening in the patient that communicates with the thoracic cavity of the patient; providing a bypass vessel having a lumen and at least one free end; passing the free end of the bypass vessel from the thoracic cavity through the opening to a position outside the body of the patient; attaching a connector to the free end of bypass vessel while the free end of the bypass vessel is outside the body of the patient; passing the free end of the bypass vessel from the position outside the body of the patient through the opening and into the thoracic cavity; and connecting the free end of the bypass vessel to a target vessel with the connector.

A method of treating or preventing a disease or condition in a subject that was previously treated with at least one thienopyridine is described. The method includes administering to the subject an effective amount of at least one reversible, short-acting P2Yi2 inhibitor. The described method can be used for subjects diagnosed with symptoms such as stable or unstable angina, vascular ischemic events, atherosclerosis, acute coronary syndrome, as well as STEMi or N-STEMI. The described method can also be used for patients having previously received a stent, such as a bare metal stent or a drug-eluting stent, and the treatment or prevention of stent thrombosis. The method can be used prior to, during, or after an invasive procedure such as coronary artery bypass grafting, percutaneous coronary intervention, or other general surgical procedure.

A method and device are disclosed directed at harvesting of vessels, such as arteries and veins, especially as required in vessel grafting procedures. The device and method discloses a cannula-like device that provides, identification, capture, manipulation, hemostasis and cleavage of branch vessels from the harvested vessel without need for further devices. In certain preferred embodiments of the disclosed method and device, the disclosed harvesting device achieves branch vessel cleavage and hemostasis without the use of heat producing means such as cautery. In addition, certain embodiments utilize a clip / coil magazine technology so as to enable severance and hemostasis of multiple branch vessels without need for removal of the device from the surgical site. Further embodiments disclose the incorporation and use of irrigants containing CO2, as well as other agents capable of stimulate release of nitric oxide from vascular endothelium are applied to subject vessels so as to enhance the viability of vessels to be harvested as graft material.

The disclosed apparatuses, methods, and systems provide for simulations of real-life bone graft procedures. One embodiment is a model that includes a base in the shape of at least a portion of a maxillary or mandibular dental arch, and includes a defect on its surface. The model also includes a multi-layer tissue model configured to overlay at least a portion of the base in a covering relationship with the defect and surrounding tissue. The multi-layer tissue model includes a gingival simulating layer, connective tissue simulating layer, and two adhesive layers. The first of the two adhesive layers connects the connective tissue simulating layer to the gingival simulating layer, and the second adhesive layer, affixed to the connective tissue simulating layer opposite the first layer, is configured to adhere the multi-layer tissue model to the base. The multi-layer tissue model also includes a removable backing covering the second adhesive layer.

A bridge vessels-proximal anastomosis supporting device for coronary artery bypass grafting and a manufacturing method thereof. The bridge vessels-proximal anastomosis supporting device for the coronary artery bypass grafting comprises an arc-shaped body (1). An elliptical bottom edge (2) is arranged at the lower part of the arc-shaped body (1), a circular port (3) is arranged at the right side of the arc-shaped body (1), a notch is formed between the rightmost end of the bottom edge (2) and the lowermost end of the port, the diameter R of the circular port (3) is 4 mm, 5 mm, 6 mm, 7 mm or 8 mm, the major axis a of the elliptical bottom edge (2) is 13 mm, and the minor axis of the elliptical bottom edge (2) is the same as R. The body (1) is formed by weaving titanium-nickel alloy wires. The bottom edge (2) and the port (3) are provided with a supporting edge (5) made of a heavy metal material, and the supporting edge (5) is fixed with the wires (4) through medical non-absorbable sutures (6) in a wrapping manner. The device can support blood vessels of an anastomosis so as to prevent the blood vessels from generating collapse or deformation due to squeezing during an operation, thereby delaying occlusion of the anastomosis after the operation, and helping complete postoperative coronary angiography easily, accurately and quickly during re-examination.

Devices and methods are disclosed for stabilizing tissue within a patient's body during a surgical operation to provide a relatively motionless surgical field, such as during a coronary artery bypass graft procedure. The devices include tissue stabilizers which engage and provide stabilization to a targeted area of tissue and further have the ability to engage and manipulate some portion of tissue within or adjacent the targeted area to improve the surgical presentation of that portion of tissue. The tissue stabilizer typically has one or more stabilizer feet which have a first foot portion configured to provide stabilization to the targeted tissue and a second foot portion moveable relative to the first foot portion for manipulating a portion of tissue to improve the surgical presentation.